**Specifications Table**TableSubject area*Biology*More specific subject area*Metagenomics*Type of data*DNA sequences*How data was acquired*Shotgun DNA sequencing using SOLiD 5500 W platform*Data format*Raw*Experimental factors*Total DNA extraction from stool samples*Experimental features*Single-end read libraries were created from 5 μg of total DNA. Shotgun metagenomic sequencing was performed on SOLiD 5500 W platform according to the recommendations of the manufacturer.*Data source location*Kazan, Russian Federation*Data accessibility*Data are available from ENA under project accession number PRJEB21338*

**Value of the data**•The data allow researchers to evaluate changes in the taxonomic and functional composition of the human gut microbiota, which is associated with the use of amoxicillin and clarithromycin.•Since the data include the metagenome profile at the 3rd time point (several weeks after the end of *H. pylori* eradication), it is possible to make assumptions about the reversibility/irreversibility of therapy-related changes.•The data can be used to estimate the distribution of antibiotic resistance genes in the genetic pool of the gut microbiota after *H. pylori* eradication therapy.•Using this data one can describe the general trends of the microbial composition variation caused by antibiotics and predict possible side effects.•The data can be used to detect the genetic markers of dysbiosis and to design a minimally invasive PCR diagnostic system.

1. Data {#s0005}
=======

The data represent the result of metagenomic shotgun-sequencing of human gut microbiota at 3 time points: before the *H. pylori* eradication therapy, immediately after 2 weeks of therapy and several weeks after the treatment. The dataset contains 15 metagenomic samples in raw reads format with 30.4 ± 10.7 mln of reads per sample (mean ± SD).

These data together with those described in \[2\] were involved in the study devoted to the gut microbiome changes caused by antimicrobial therapy \[1\].

These data together with those described in [@bib2] were involved in the study devoted to the gut microbiome changes caused by antimicrobial therapy [@bib1].

Detailed description of samples is given in [Table 1](#t0005){ref-type="table"}.Table 1Description of samples. "Time point" column shows the time of sample collection: "1" means at the start of the therapy, "2" -- immediately after therapy, "3" -- several weeks after therapy.Table 1Patient IDGenderDiagnosisSample IDTime point1MaleGastroesophageal reflux disease1HP12HP23HP3 (3.5 weeks after treatment)2MaleChronic gastroduodenitis26HP127HP228HP3 (4 weeks after treatment)3FemaleGastroesophageal reflux disease41HP142HP243HP3 (11 weeks after treatment)4FemaleChronic gastroduodenitis31HP153HP254HP3 (4 weeks after treatment)5MaleGastroesophageal reflux disease63HP164HP265HP3 (2.5 weeks after treatment)

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Sample collection {#s0015}
----------------------

Fifteen stool samples from 5 patients with symptoms of stomach and/or duodenum disease and *Helicobacter pylori* detected by endoscopy were taken for analysis. According to the Maastricht V Consensus and recommendations of Russian Gastroenterological Association, patients had been prescribed a two-week eradication therapy consisted of amoxicillin (1000 mg bid), clarithromycin (500 mg bid) and proton pump inhibitors at a standard dose accompanied by bismuth subsalicylate (240 mg bid) [@bib3]. Samples were collected in the Polyclinic Department of the Republican Clinical Hospital \#2 (Kazan). The study was approved by the Local Ethics Committee of the Kazan Federal University. Prior written informed consent was obtained from all patients.

2.2. Sample preparation and sequencing {#s0020}
--------------------------------------

Fecal samples were collected in the individual plastic containers, avoiding contamination with urine or toilet tissue. 10--20 g of samples were instantly frozen with subsequent storage at −20 °C, or were used for DNA extraction immediately after sampling.

Total DNA (5 μg) from fecal samples was extracted using the Purelink Genomic DNA Extraction Kit (Invitrogen, USA). Metagenomic single-end library preparation and shotgun sequencing on SOLiD 5500 W platform was performed according to the recommendations of the manufacturer (LifeTechnologies, USA). The resulting color-spaced reads with length of 50 bp were converted to the base-space format.
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